Thyrotropin secreting pituitary microadenoma and lung adenocarcinoma treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) Erlotinib and Osimertinib: a case report

Antonio Di Ieva; See Yoon Kim; David Lewis; Pirooz Poursoltan; Veronica Preda

doi:10.1210/jendso/bvac150.1068

Thyrotropin secreting pituitary microadenoma and lung adenocarcinoma treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) Erlotinib and Osimertinib: a case report

Antonio Di Ieva, See Yoon Kim, David Lewis, Pirooz Poursoltan, Veronica Preda

Macquarie Medical School

Research output: Contribution to journal › Meeting abstract › peer-review

57 Downloads (Pure)

Original language	English
Article number	ODP359
Pages (from-to)	A513-A514
Number of pages	2
Journal	Journal of the Endocrine Society
Volume	6
Issue number	Supplement 1
DOIs	https://doi.org/10.1210/jendso/bvac150.1068
Publication status	Published - 1 Nov 2022
Event	ENDO 2022 Annual Meeting of the Endocrine Society - Atlanta, United States Duration: 11 Jun 2022 → 14 Jun 2022

Bibliographical note

Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

EGFR
thyrotropin
pituitary adenoma

Access to Document

10.1210/jendso/bvac150.1068Licence: CC BY-NC-ND

Publisher version (open access)Final published version, 73.7 KBLicence: CC BY-NC-ND

Cite this

Ieva, A. D., Kim, S. Y., Lewis, D., Poursoltan, P., & Preda, V. (2022). Thyrotropin secreting pituitary microadenoma and lung adenocarcinoma treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) Erlotinib and Osimertinib: a case report. Journal of the Endocrine Society, 6(Supplement 1), A513-A514. Article ODP359 . https://doi.org/10.1210/jendso/bvac150.1068

@article{cf2faf96e9e14ac6b04f028c70f1d1c8,

title = "Thyrotropin secreting pituitary microadenoma and lung adenocarcinoma treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) Erlotinib and Osimertinib: a case report",

keywords = "EGFR, thyrotropin, pituitary adenoma",

author = "Ieva, \{Antonio Di\} and Kim, \{See Yoon\} and David Lewis and Pirooz Poursoltan and Veronica Preda",

note = "Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.; ENDO 2022 Annual Meeting of the Endocrine Society ; Conference date: 11-06-2022 Through 14-06-2022",

year = "2022",

month = nov,

day = "1",

doi = "10.1210/jendso/bvac150.1068",

language = "English",

volume = "6",

pages = "A513--A514",

journal = "Journal of the Endocrine Society",

issn = "2472-1972",

publisher = "Endocrine Society",

number = "Supplement 1",

}

Ieva, AD, Kim, SY, Lewis, D, Poursoltan, P & Preda, V 2022, 'Thyrotropin secreting pituitary microadenoma and lung adenocarcinoma treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) Erlotinib and Osimertinib: a case report', Journal of the Endocrine Society, vol. 6, no. Supplement 1, ODP359 , pp. A513-A514. https://doi.org/10.1210/jendso/bvac150.1068

Thyrotropin secreting pituitary microadenoma and lung adenocarcinoma treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) Erlotinib and Osimertinib: a case report. / Ieva, Antonio Di; Kim, See Yoon; Lewis, David et al.
In: Journal of the Endocrine Society, Vol. 6, No. Supplement 1, ODP359 , 01.11.2022, p. A513-A514.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Thyrotropin secreting pituitary microadenoma and lung adenocarcinoma treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) Erlotinib and Osimertinib

T2 - ENDO 2022 Annual Meeting of the Endocrine Society

AU - Ieva, Antonio Di

AU - Kim, See Yoon

AU - Lewis, David

AU - Poursoltan, Pirooz

AU - Preda, Veronica

N1 - Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2022/11/1

Y1 - 2022/11/1

KW - EGFR

KW - thyrotropin

KW - pituitary adenoma

U2 - 10.1210/jendso/bvac150.1068

DO - 10.1210/jendso/bvac150.1068

M3 - Meeting abstract

SN - 2472-1972

VL - 6

SP - A513-A514

JO - Journal of the Endocrine Society

JF - Journal of the Endocrine Society

IS - Supplement 1

M1 - ODP359

Y2 - 11 June 2022 through 14 June 2022

ER -